Early research (Phase 1)Study completedNCT01189942
What this trial is testing
FOLFIRI Plus OMP-21M18 as 1st or 2nd-line Treatment in Subjects With Metastatic Colorectal Cancer
Who this might be right for
Colorectal Cancer
OncoMed Pharmaceuticals, Inc. 18